The PneumoADIP team is committed to ensuring lifesaving pneumococcal vaccines reach the children who urgently need them.
Print this pageOur Team
PneumoADIP Team
GAVI’s PneumoADIP is a dedicated team of experts and specialists based at the Johns Hopkins Bloomberg School of Public Health and is supported by a $30 million grant from GAVI Alliance. Our team draws experience from a variety of sectors and are committed to ensuring lifesaving pneumococcal vaccines reach the children who urgently need them.
Allyson Bear
Patricia Boyd
Julie Buss
Thomas Cherian
Matt Coles
Maria Deloria-Knoll
Patricia Hahn-Esposito
Hope Johnson
Benedicta Kim
Hans Kvist
Orin Levine
Jennifer Moisi
Michelle Moncrieffe-Foreman
Kate O'Brien
Lois Privor-Dumm
Beverly Thompson
Damian Walker
Joe Agostino
Financial Analyst
jagostino@jhsph.edu
Mr. Agostino is the Budget Specialist for PneumoADIP. Prior to joining the team he worked for Wachovia Securities Private Client Group, where he focused on budgeting and performance reporting. A graduate of Towson University in Maryland, with a degree in finance, Mr. Agostino is originally from New York.
Allyson Bear
Associate Director of Vaccine Access and Implementation
abear@jhsph.edu
Ms. Bear manages the strategic information and monitoring and evaluation systems for PneumoADIP and is also responsible for knowledge management. She joined PneumoADIP with a decade of experience working with developing countries to implement and evaluate health and development programs. She has lived and/or worked in Africa, South East Asia, India and the Middle East, and speaks three languages. Ms. Bear has a Masters of Public Health from the Johns Hopkins Bloomberg School of Public Health.
Patricia Boyd
Administrative Coordinator
pboyd@jhsph.edu
Ms. Boyd is an Administrative Coordinator for the PneumoADIP team, providing administrative support to the entire team. Prior to joining the team, Ms. Boyd worked in administration for 15 years in the Division of Disease Control.
Julie Buss
Communications Manager
jbuss@jhsph.edu
Before joining PneumoADIP, Ms. Buss held a research fellowship in the department of Molecular Microbiology and Bioinformatics at Chiron Vaccines, Italy and has also worked in international business and trade in Washington, DC. She holds a degree in biochemistry and an MPH from the Johns Hopkins Bloomberg School of Public Health. Ms. Buss is a Communications Manager for PneumoADIP.
Thomas Cherian
WHO Liaison to ADIP Team
cheriant@who.int
Dr. Thomas Cherian is a scientist in the Initiative for Vaccine Research at WHO, coordinating a team responsible for research on vaccines against respiratory and vectorborne pathogens. Previously, Dr. Cherian was a Professor of Paediatrics at the Christian Medical College in Vellore, India. He is also a Senior Associate in the Department of International Health at the Johns Hopkins Bloomberg School of Public Health, Baltimore. He has authored/coauthored more than 90 scientific articles and book chapters.
Matt Coles
Research Service Analyst
mcoles@jhsph.edu
Mr. Coles manages all the contracts for the PneumoADIP team. Before joining PneumoADIP, he worked as a Program Manager for the CDC Foundation in Atlanta, Georgia where he was responsible for the Global Health Programs. He also served as a Health Extension Volunteer with the U.S. Peace Corps in The Gambia, West Africa from 2000-2003.
Maria Deloria-Knoll
Director, Vaccine Research
mknoll@jhsph.edu
Dr. Knoll has over 15 years of experience in the design, conduct, and analysis of clinical trials and epidemiologic studies. She spent 13 years at the National Institute of Allergy and Infectious Diseases at the NIH and, most recently, 3 years at the Feinberg School of Medicine at Northwestern University. Her clinical trials experience includes close working relationships with many large and mid-sized vaccine manufacturers.
Hope Johnson
Research Associate
hjohnson@jhsph.edu
Dr. Johnson is an Epidemiologist with PneumoADIP. She recently completed her Ph.D. in Global Disease Epidemiology and Control, with a Certificate in Vaccine Science and policy at the Johns Hopkins Bloomberg School of Public Health where she previously completed her MPH degree. She has nine years of experience in public health and epidemiologic research, including clinical trials and the provision of technical assistance in epidemiology, disease surveillance, and health information systems internationally.
Benedicta Kim
Communications Manager
hekim@jhsph.edu
Ms. Kim is the Communications Manager for PneumoADIP. She has a background in journalism, research, small business management, and community-based programs. Most recently, Ms. Kim worked as a consultant for the PneumoADIP website. Prior to that, she was a research assistant at JHSPH Center for Prevention and Early Intervention.
Hans Kvist
Director, Communications
hkvist@jhsph.edu
Before joining PneumoADIP, Mr. Kvist worked as the Global Communication Manager for Novartis in Switzerland. Mr. Kvist came to the PneumoADIP team with more than 20 years of experience from the pharmaceutical industry. For the past 15 years, Mr. Kvist has worked with communications on a global level where his work has included scientific symposia program development, publication planning, and public relations.
Orin Levine
Executive Director
olevine@jhsph.edu
Before coming to Johns Hopkins as an Associate Professor in the Department of International Health, Dr. Levine spent five years at the CDC followed by three years with the US National Institutes of Health. Dr. Levine has authored/coauthored more than 50 original research papers and book chapters, including more than 25 on the subject of meningitis and pneumonia and their prevention by vaccination.
Jennifer Moisi
Surveillance Officer
jmoisi@jhsph.edu
Ms. Moisi is the Surveillance Officer for PneumoADIP. She is currently pursuing a Ph.D in International Health, Disease Prevention and Control at Johns Hopkins Bloomberg School of Public Health where she received a master’s degree in biostatistics. Prior to her appointment as a Surveillance Officer, she worked as a Research Assistant for pneumoADIP in the U.S., in Kenya, and in Mali. She helped to assess and improve surveillance networks and data collection techniques.
Michelle Moncrieffe-Foreman
Communications Manager
mmoncrie@jhsph.edu
Ms. Moncrieffe-Foreman is the Communications Manager for PneumoADIP. She has a background in journalism, health communications, and community-based programs. Most recently, Ms. Moncrieffe-Foreman worked as a consultant for the American Lung Association of Minnesota. Prior to that, she spent ten years working as a journalist and communications consultant in the United States, Tanzania, and the United Kingdom.
Kate O'Brien
Deputy Director, Vaccine Research
klobrien@jhsph.edu
For the past five years Dr. O'Brien has been a faculty member and the Associate Director of Infectious Disease Studies for the Center for American Indian Health at the Johns Hopkins Bloomberg School of Public Health. Her research has focused on vaccine preventable diseases of childhood, with a particular emphasis on S. pneumoniae. Dr. O'Brien is a consultant to WHO on pneumococcal conjugate vaccine trials.
Lois Privor-Dumm
Director, Vaccine Access and Implementation
lprivord@jhsph.edu
Ms. Privor-Dumm spent 17 years working in industry in various marketing, operations and finance positions prior to joining the Johns Hopkins Bloomberg School of Public Health. Lois is the Director, Vaccine Access and Implementation for PneumoADIP, in addition to her role as Health Director, Communication and Strategy for the Hib Initiative. Ms. Privor-Dumm holds a Masters in International Business from the University of South Carolina.
Damian Walker
Health Economist
dgwalker@jhsph.edu
Damian Walker, PhD, is a health economist with 10 years experience of performing economic evaluations of health care programs in low- and middle-income countries. He has published more than 40 peer-reviewed articles. Damian is the lead author of the forthcoming WHO guidelines on standardising economic evaluations of immunization programs. Damian has been appointed as an expert on many technical working groups on the cost and cost-effectiveness of health technologies. He is a co-convenor of the Campbell and Cochrane Economics Methods Group, with particular responsibility for issues related to low- and middle-income countries. Damian holds an Honorary Lectureship at the London School of Hygiene and Tropical Medicine, is an International Visiting Faculty Member of the James P. Grant School of Public Health, BRAC University, Bangladesh, and is an adjunct Scientist at the International Centre for Diarrhoeal Disease research, Bangladesh (ICDDR,B).